Mr Mrs Miss Ms Dr Other

Miss
Eleanor
James

European Patent Attorney

York Office

Life sciences

Telephone. +44(0) 190 4732 120
Email. ejames@hgf.com
Vcard
Linkedin

Experience

Eleanor graduated from the University of Oxford in 2019 with a BA in Biomedical Sciences. During her time at university, Eleanor focused her studies on immunology, immunotherapeutics and the biology of brain disorders. Her final year project involved research into the molecular mechanisms underlying the pathology of Alzheimer’s Disease. Eleanor joined HGF in September 2019 as a Trainee Patent Attorney working in the Life Sciences team. She has since completed a Postgraduate Certificate in Intellectual Property at Bournemouth University and has passed several of the European qualifying examinations.

Eleanor has experience with drafting patent applications and global prosecution, with a particular focus on UK and European prosecution. Eleanor helps manage global portfolios and co-ordinate prosecution strategies. Eleanor works on a variety of different technologies, particularly those in the field of cell and gene therapy. Eleanor works with a range of clients including universities, start-ups, independent research institutes and small to medium enterprises. She has particular experience in drafting and prosecuting T cell and TCR related applications.

Specialisms

Industries

Services

Qualifications

Trainee

BA

BA in Biomedical Sciences from the University of Oxford

POSTGRADUATE DIPLOMA OR CERTIFICATE

Postgraduate Certificate in Intellectual Property with Distinction from Bournemouth University

Publications

Celebrating exam success at HGF

View publication online

HGF Futures Life Sciences – Join our open day in London

View publication online

CSR

Eleanor has volunteered as a mentor with a charity supporting young students who, as a result of their socioeconomic background, face barriers in education and work.

Related News

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

The Antibody Series #5 | Epitope-defined antibody claims: when “binds to this epitope” becomes a risk of insufficiency

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews decisions made at the EPO; here, they reviewed an appeal in opposition proceedings after the revocation …

Read article

The Deity Shoes case: a question of design activity and the constraints on a designer’s freedom

The footwear brand Deity Shoes sought to enforce their Community Design rights, both registered and unregistered, against Mundorama Confort and Stay Design. However, Mundorama Confort and Stay Design found fault …

Read article

The Antibody Series #4 | pH points in antibody claims: when “same pH ” becomes an addition of matter

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions; in this case, they reviewed a revocation in opposition of a patent relating to …

Read article

The Antibody Series #3 | Antibody code names in claims: why “ACZ885” is not sufficient to define the antibody

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions. In this case, they examined a claim that identified an antibody by an internal …

Read article
See all updates

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.

Contact us